If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKooth Plc Regulatory News (KOO)

Share Price Information for Kooth Plc (KOO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 307.00
Bid: 304.00
Ask: 310.00
Change: 0.00 (0.00%)
Spread: 6.00 (1.974%)
Open: 307.00
High: 307.00
Low: 302.00
Prev. Close: 307.00
KOO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

26 Jul 2022 07:00

RNS Number : 6742T
Kooth PLC
26 July 2022
 

 

26 July 2022

Kooth plc

("Kooth" or the "Group")

Trading update

 

Kooth, the UK's leading digital mental health platform, announces a trading update for the six-month period to 30 June 2022. All figures relate to this period, unless otherwise stated.

 

The Group has a strong pipeline of contracts which are expected to be signed in the second half of this year and has high retention rates of existing business. Therefore, the Group remains confident of delivering revenue for the full year within market expectations. Kooth continues to make good progress with its mission to provide personalised digital mental health care which is both cost effective and clinically proven.

 

For children and young people, Kooth has cemented its position as the leader in its field and, as part of data collected to support NHS England's strategy of significantly expanding access to mental health support across this demographic, the Group has been shown to be the number one provider of mental health access in the UK. Kooth Adult has seen new wins in regions including Greater Manchester, Northumberland, Devon and County Durham and Tees Valley. The Group continues to work on establishing its capability in the USA, and has recently won its first pilot in the region, which will go live in H2 2022. Kooth Work has also seen success in its strategy of focusing on supporting frontline and key workers, winning new contracts with RetailTrust, Grocery Aid, and multiple multi-academy trusts to support teaching staff.

 

The directors believe that the ongoing transition within UK public healthcare from 135 Clinical Commissioning Groups ("CCGs") to 42 new Integrated Care Systems ("ICSs") provides an opportunity for the group to deepen further its relationships in this sector. In the short term there is evidence that the transition is delaying some buying decisions, but overall Kooth expects the changes to leave the Group in a stronger position.

 

Kooth has a strong balance sheet, with net cash as at 30 June 2022 of £8.3m (FY21: £7.1m), supporting continued investment for long-term growth. The Group's investment strategy continues to focus on business development, platform investment and U.S. expansion.

 

The Group's half year results in respect of the six months to 30 June 2022 will be announced in September 2022.

 

Tim Barker, Chief Executive Officer of Kooth, said:

"We have continued to expand our business, grow our service offering and target long-term, sustainable growth. This is underlined by our strong pipeline of new business opportunities along with the high rate of retention we see with our existing customers. This retention, and our strong balance sheet, allow us to invest for long-term growth, including accelerating business development, further platform investment and focus on US expansion, particularly following our maiden pilot contract there. The breadth of our data, combined with the clinically validated nature of our platform, ensures that Kooth remains a market leader and is able to help people find the treatment they need and the NHS to continue providing support for their patients."

 

- Ends -

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ('MAR'). Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain. The person responsible for this announcement is Sanjay Jawa, CFO.

 

Enquiries:

Kooth plc

investorrelations@kooth.com

Tim Barker, CEO

Sanjay Jawa, CFO

Panmure Gordon, Nominated Adviser and Joint Broker

 

Corporate Finance:

Dominic Morley, Ailsa MacMaster

+44 (0) 20 7886 2500

 

Corporate Broking:

Erik Anderson

Stifel, Joint Broker

+44 (0) 20 7710 7600

Ben Maddison, Nick Adams, Nicholas Harland, Richard Short

FTI Consulting

kooth@fticonsulting.com

Jamie Ricketts, Alex Shaw, Usama Ali

 

 

About Kooth plc:

 

Kooth (AIM:KOO) is the UK's leading digital mental health platform. Our mission is to provide accessible and safe spaces for everyone to achieve better mental health. Our platform is clinically robust and accredited to provide a range of therapeutic support and interventions. All our services are predicated on easy access to make early intervention and prevention a reality.

 

Our three services are:

 

· Kooth: for children and young persons

· Kooth: for Adults

· Kooth Work: for employees

 

Kooth is a fully safeguarded and pre-moderated community with a library of peer and professional created content, alongside access to experienced online counsellors. There are no thresholds for support and no waiting lists. Currently, Kooth sees over 4,000 logins a day.

 

For adults, Kooth operates across distinct locations and serves specific cohorts, including parents, teachers, victims of crime, and those who have suffered from or continue to experience domestic violence. It is also offered as a benefit by a number of corporate organisations delivering anonymous digital mental health support services to employees.

 

Kooth is the only digital mental health provider to hold a UK-wide accreditation from the British Association of Counselling and Psychotherapy (BACP).

 

In 2021, Kooth was named 'Best Newcomer' at the European Mediscience Awards, winner in the category of 'Tech for Good' at the UK Tech Awards and recognised as the 'HealthTech Pioneer of the Year' at the UK Business Tech Awards for its role in 'Supporting the Nation's Mental Health'.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLGDRCDDDGDU
12
Date   Source Headline
30th Apr 20247:00 amRNSDirectorate Change
23rd Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
26th Mar 20247:00 amRNSAnnual Financial Report
1st Mar 20247:00 amRNSBlock Listing Six Monthly Return
22nd Jan 20247:00 amRNSTrading Statement
9th Jan 20247:00 amRNSLaunch of California contract
14th Nov 202311:41 amRNSHolding(s) in Company
27th Oct 202310:19 amRNSAwards under Incentive Plan & PDMR dealing
16th Oct 20235:27 pmRNSHolding(s) in Company
16th Oct 20233:06 pmRNSHolding(s) in Company
11th Oct 202311:24 amRNSHolding(s) in Company
5th Oct 20236:25 pmRNSDirector/PDMR Shareholding
2nd Oct 20237:00 amRNSAppointment of Nominated Adviser and Broker
26th Sep 20232:07 pmRNSInvestor Presentation via Investor Meet Company
22nd Sep 20233:59 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSHalf-year Results
12th Sep 20232:11 pmRNSHolding(s) in Company
1st Sep 20237:00 amRNSBlock listing application
19th Jul 20237:18 amRNSInvestor Presentation via Investor Meet Company
4th Jul 202310:48 amRNSResult of Placing, PDMR Dealings & TVR
4th Jul 20237:01 amRNSProposed placing to raise approximately £10million
4th Jul 20237:00 amRNS$188m four year contract in California
29th Jun 202311:56 amRNSResult of 2023 AGM, update on California contract
23rd May 20231:58 pmRNSHolding(s) in Company
6th Apr 202310:55 amRNSInvestor Presentation via Investor Meet Company
4th Apr 20239:25 amRNSNotice of AGM
4th Apr 20237:00 amRNSFY22 Results
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 202311:05 amRNSSecond Price Monitoring Extn
16th Mar 202311:00 amRNSPrice Monitoring Extension
16th Mar 20237:00 amRNSSignificant US contract in California
19th Jan 20237:00 amRNSTrading Update
17th Jan 20237:00 amRNSInvestor Presentation
6th Dec 20226:15 pmRNSNotification of Transactions of Directors
9th Nov 20227:00 amRNSHolding(s) in Company
17th Oct 20224:41 pmRNSSecond Price Monitoring Extn
17th Oct 20224:35 pmRNSPrice Monitoring Extension
13th Oct 20227:00 amRNSContract with State of Pennsylvania formalised
27th Sep 20227:01 amRNSHalf Year Results
27th Sep 20227:00 amRNSSignificant US Contract Win
26th Jul 20227:00 amRNSTrading Statement
7th Jun 20223:11 pmRNSResult of AGM
13th May 20227:00 amRNSCapital Markets Day
31st Mar 20226:14 pmRNS2021 Annual Report and Notice of AGM
29th Mar 20227:00 amRNSFinal Results
16th Mar 20227:00 amRNSUpdate on strategic progress
20th Jan 20227:00 amRNSTrading Statement
29th Dec 20214:20 pmRNSHoldings in Company
13th Dec 20217:00 amRNSAppointment of Joint Broker
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.